Deadline: 26-Jun-25
Pfizer has launched the Competitive Grant Program to Develop Educational Initiatives for Implementation and Therapy Management of B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM).
General Area of Interest
- Projects that will be considered for Pfizer support will focus on increasing healthcare professional understanding and competency in the use and management of BCMA BsAbs for the treatment of Relapsed/Refractory Multiple Myeloma, and may address one or more of the following areas:
- Sharing successful practice models for BCMA BsAb implementation, identifying challenges and presenting effective solutions including coordination of care among multidisciplinary teams
- Addressing educational gaps in the community oncology setting regarding initiation of care, guidance on the patient transition from academic to community setting, and assessment and management of adverse events in patients receiving BCMA BsAbs (i.e. CRS, ICANS, infection)
- Understanding the emerging evidence for the evolving role of BCMA BsAbs in earlier lines of therapy
- Equipping patients and their care partners with the necessary knowledge and resources for BCMA BsAb therapy
- Understanding the comfort level of implementing BCMA BsAbs therapy management
Funding Information
- Individual projects requesting up to $250,000 USD will be considered. The estimated total available budget related to this RFP is $500,000 USD.
Target Audience
- Oncologists, oncology nurses and nurse practitioners, physician assistants, pharmacists and other healthcare professionals involved in the care and treatment of patients with relapsed/refractory multiple myeloma.
Eligibility Criteria
- Applicant organizations to this RFP must be based in United States
- The following may apply: medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to patient and/or healthcare professional education and/or healthcare improvement.
- Only organizations are eligible to receive grants, not individuals or physician-owned medical practices.
- If the project involves multiple departments within an institution and/or between different institutions/organizations/associations, all institutions must have a relevant role, and the requesting organization must have a key role in the project.
For more information, visit Pfizer.
